Viewing Study NCT00482963



Ignite Creation Date: 2024-05-05 @ 5:34 PM
Last Modification Date: 2024-10-26 @ 9:33 AM
Study NCT ID: NCT00482963
Status: COMPLETED
Last Update Posted: 2013-07-15
First Post: 2007-06-05

Brief Title: A Study of the Drug Interactions Between a Hormonal Emergency Contraception and an HIV Medication
Sponsor: University of Colorado Denver
Organization: University of Colorado Denver

Study Overview

Official Title: A Pilot Study of the Pharmacokinetic Interactions Between the Hormonal Emergency Contraception Plan B and Efavirenz
Status: COMPLETED
Status Verified Date: 2013-07
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The purpose of this study is to determine if blood levels of the hormonal emergency contraceptive agent Plan B are altered by concomitant use with the HIV medication efavirenz
Detailed Description: The use of hormonal contraceptive pills in women with HIV is complex due to potential interactions between these agents and HIV medications HIV-infected women taking efavirenz have an even greater need for effective birth control as this medication may cause severe brain damage to a developing fetus The use of an emergency contraceptive agent in cases of unprotected sex or condom failure can prevent pregnancy This study seeks to establish that Plan B can be used effectively and safely in women taking efavirenz

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None